BrainStorm Cell Therapeutics
BCLI
#10105
Rank
NZ$12.21 M
Marketcap
$1.87
Share price
14.87%
Change (1 day)
-86.27%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total debt

Total debt on the balance sheet as of December 2024 : NZ$1.2 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total debt is NZ$1.2 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

BrainStorm Cell Therapeutics - Total debt on balance sheet (from 2002 to 2024)

Total debt by year

Year Total debt Change
2022-12-31NZ$6.44 M-13.3%
2021-12-31NZ$7.43 M-25.66%
2020-12-31NZ$10 M184.71%
2019-12-31NZ$3.51 M
2018-12-31N/A
2010-12-31NZ$0.17 M-65.14%
2009-12-31NZ$0.5 M-33.27%
2008-12-31NZ$0.76 M-62.05%
2007-12-31NZ$2.01 M25.87%
2006-12-31NZ$1.59 M
2006-03-31NZ$0.8 M
2004-03-31NZ$0.04 M22.65%
2003-03-31NZ$0.03 M65.05%
2002-03-31NZ$0.02 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$44.65 B 3,709,761.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.31 B 109,438.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.18 B 15,662.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.08 B 920,775.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.15 B 13,076.39%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA